Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2021.07.16.452617

Low dose AKT inhibitor miransertib cures PI3K-related vascular malformations in preclinical models of human disease

Kobialka, P.·Sabata, H.·Vilalta, O.·Angulo-Urarte, A.·Muixi, L.·Zanoncello, J.·Munoz-Aznar, O.·Olaciregui, N. G.·Lavarino, C.·Celis, V.·Rovira, C.·Lopez-Fernandez, S.·Baselga, E.·Mora, J.·Castillo, S. D.·Graupera, M.
View original source ↗Export metadata ↓

Abstract

Low-flow vascular malformations are congenital overgrowths composed by abnormal blood vessels potentially causing pain, bleeding, and obstruction of different organs. These diseases are caused by oncogenic mutations in the endothelium which result in overactivation of the PI3K/AKT pathway. Lack of robust in vivo preclinical data has prevented the development and translation into clinical trials of specific molecular therapies for these diseases. Here, we describe a new reproducible preclinical in vivo model of PI3K-driven vascular malformations using the postnatal mouse retina. This model reproduces human disease with Pik3ca activating mutations expressed in a mosaic pattern and vascular malformations formed in veins and capillaries. We show that active angiogenesis is required for the pathogenesis of vascular malformations caused by activating Pik3ca mutations. Using this model, we demonstrate that low doses of the AKT inhibitor miransertib both prevents and induces the regression of PI3K-driven vascular malformations. We confirmed miransertib efficacy in isolated human endothelial cells with genotypes spanning most of human low-flow vascular malformations. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=69 SRC="FIGDIR/small/452617v1_ufig1.gif" ALT="Figure 1"> View larger version (31K): org.highwire.dtl.DTLVardef@15b29b6org.highwire.dtl.DTLVardef@fa9f8org.highwire.dtl.DTLVardef@6001d8org.highwire.dtl.DTLVardef@11926c5_HPS_FORMAT_FIGEXP M_FIG C_FIG Low-flow vascular malformations are caused by PI3K signalling overactivation in endothelial cells. We have generated an optimised and robust preclinical system of PI3K-driven vascular malformations by inducing the mosaic expression of Pik3caH1047R in the retinal angiogenic endothelium. This preclinical model displays traits constituting the main hallmarks of the pathogenesis of low-flow blood vascular malformations: overactivation of PI3K signalling (high phospho-S6), vascular compartment specificity, loss of pericyte coverage, and endothelial cell hyperproliferation. Using this preclinical model we report that low dose AKT inhibitor miransertib prevents and regress PI3K-driven vascular malformations.

Explore related subjects

molecular biologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kobialka, P., Sabata, H., Vilalta, O., Angulo-Urarte, A., Muixi, L., Zanoncello, J., Munoz-Aznar, O., Olaciregui, N. G., Lavarino, C., Celis, V., Rovira, C., Lopez-Fernandez, S., Baselga, E., Mora, J., Castillo, S. D., Graupera, M.. 2021-07-16. Low dose AKT inhibitor miransertib cures PI3K-related vascular malformations in preclinical models of human disease. https://doi.org/10.1101/2021.07.16.452617

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Hypoxic Stress Induces LARP1-Driven Stress Granules That Protect mRNAs from Decay to Sustain Mitotic Cell Cycle Progression

Hypoxia is a defining feature of solid tumours that elicits extensive transcriptional and post-transcriptional adaptations. Stress granules (SGs) are frequently observed under hypoxia, yet how they assemble and whether they contribute to hypoxic gene regulation remain poorly understood. Here, we show that hypoxia induces SGs through an assembly mechanism distinct from that of classical acute stresses. Hypoxia SG formation occurs independently of the integrated stress response and instead requires the HIF1-REDD1-mTORCC1-4EBP1 axis. Remarkably, hypoxia SGs assemble despite robust ongoing translation, suggesting that additional mechanisms lower the threshold for RNA condensation. We identify LARP1 as a potential determinant of this process, where it promotes G3BP-dependent SG assembly specifically during hypoxia. Despite their distinct assembly mechanism, hypoxia and arsenite SGs recruit broadly similar RNA populations, with selective differences validated by single-molecule FISH, suggesting that conserved principles govern RNA partitioning across different SG states. Functionally, sequestration into hypoxia SGs correlates with enhance protein expression whereby a subset of mRNAs are protected from decay. Transcriptomic analyses further reveal that this protection sustains a broader gene-expression program enriched for MCM complex and mitotic cell-cycle regulators. Accordingly, disruption of hypoxia SGs reduces mitotic progression and proliferative competence during prolonged hypoxia. Together, our findings establish LARP1-mediated condensation as a mechanism that enables SG assembly despite ongoing translation and reveal that SG sequestration preserves selected mRNAs from decay to sustain the gene-expression programs required for long-term adaptation to hypoxia.

molecular biology↗
bioRxiv2026

Age-associated repression of HNF4α is a driver and potential therapeutic target in liver metabolic dysfunction

Aging is a major risk factors for metabolic dysfunction-associated steatotic liver disease (MASLD). However, the mechanisms by which aging disrupts hepatocyte transcriptional networks to drive metabolic dysfunction remain poorly understood. Hepatocyte nuclear factor 4 alpha (HNF4) is a master regulator of hepatocyte identity and metabolic homeostasis, but its role in liver aging has not been defined. Here, we perform a comprehensive multi-omic profiling of young and aged mouse livers combined with targeted HNF4 functional studies to define how aging remodels HNF4-dependent gene regulation and whether HNF4 can be a target to reverse age-associated liver dysfunction. Despite preserved HNF4 expression with age, aging was associated with reduced HNF4 chromatin occupancy and transcriptional activity, accompanied by epigenetic remodeling, including changes in histone acetylation, chromatin accessibility, and DNA methylation. Integration and comparison of HNF4 CUT&RUN with hepatocyte-specific Hnf4a deletion in young and aged livers identified high-confidence overlapping but distinct young- and old- specific HNF4 target gene networks. In young hepatocytes, HNF4 coordinates two complementary transcriptional programs: activation of genes governing hepatocyte identity, lipid metabolism, and metabolic function, while simultaneously inhibiting alternative developmental, proliferative, and inflammatory programs. Spatial transcriptomic analyses further revealed zone-specific specialization of HNF4-dependent gene programs. Aging selectively disrupted these regulatory networks, resulting in compromised liver identity and metabolic gene programs, de-repression of inflammatory pathways and alternative cellular identity programs and disrupted hepatocyte zonation, consistent with age-dependent lipidomic and metabolic changes, hepatic fat accumulation, and immune infiltration. Hepatocyte-specific Hnf4a deletion in young mice recapitulated key features of liver aging, including impaired hepatocyte identity, metabolic dysfunction, steatosis, inflammatory activation and altered hepatic immune-cell composition, while deletion in aged mice further exacerbated steatosis, inflammation, and hepatic dysfunction. Conversely, hepatocyte-specific HNF4 restoration in aged mice significantly reduced hepatic steatosis and lipid accumulation, restored fatty acid metabolic programs, and partially reversed age-associated transcriptional changes. However, inflammatory and interferon-associated programs were not uniformly reversed, revealing differential responsiveness of metabolic and inflammatory pathways to HNF4 restoration. Together, these findings identify age-associated impairment of HNF4 activity as a functional contributor to liver aging, linking dysregulation of hepatocyte identity, metabolic homeostasis, and inflammatory control to age-associated hepatic dysfunction. Importantly, the selective reversibility of metabolic defects following HNF4 restoration establishes HNF4 as a promising strategy for preserving hepatocyte homeostasis and reversing age-associated hepatic metabolic dysfunction.

molecular biology↗
bioRxiv2026

A Human Tumor Virus Recruits HSP70 Chaperone to Remodel Its Replisome on DNA

Human Merkel cell polyomavirus (MCV) large T (LT) protein functions as a replication helicase analogous to the cellular MCM complex but requires a second MCV protein, small T (sT), for efficient LT-initiated replication. Both LT and sT encode highly-conserved DnaJ domains that bind to the cellular refolding molecule, heat shock protein 70 (HSP70). Using single-molecule imaging and FRET, we find that sT recruits dimeric HSP70 to serve as a molecular bridge between sT and LT on DNA and that this complex facilitates remodeling LT into a functional double-hexameric helicase. Disruption of LT-HSP70-HSP70-sT interaction with HSP70 inhibitors or by mutations to the LT-sT DnaJ domains collapse the LT-HSP70-HSP70-sT complex, abolishing sT-enhanced LT dodecamerization and ATP-dependent DNA unwinding. Assembly of virus-free mammalian MCM3, MCM4 and MCM6 in nuclear extracts similarly recruits HSP70 to DNA suggesting that Hsp70 remodeling is used for efficient eukaryotic assembly of the multi-protein replication machinery.

molecular biology↗